Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615095 · ClinicalTrials.gov registry record
Differential Risks for Melanoma: p16 and DNA Repair
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 323
- Enrollment target
NCT00615095: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00615095 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 323 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00615095 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 323 participants
- Enrollment target
Study Summary
The goal of this study is to find out if some people are more likely to get melanoma, a form of skin cancer, than others. People respond to the environment in different ways. Some may be born with genes that make them more likely to get this type of skin cancer. Genes are made up of DNA. DNA damage is one of the first steps in developing cancer. Each person has many ways to repair normal damage to their genes. Some people may have a lower level of this repair and that may make them more likely to get cancer. Some genes are important for DNA repair. The genes we want to test are thought to affect the rate at which DNA can be repaired. We also want to find out if sun habits are related to these levels of DNA repair or genetic mutations.
Interventions
- OTHER self-administered questionnaire and blood draw
- OTHER health questionnaire, blood draw and skin exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 1997-02 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00615095
The ClinicalTrials.gov registry entry for NCT00615095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which self-administered questionnaire and blood draw is the first listed.
NCT00615095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00615095 about?
NCT00615095 is a clinical study titled "Differential Risks for Melanoma: p16 and DNA Repair". The goal of this study is to find out if some people are more likely to get melanoma, a form of skin cancer, than others. People respond to the environment in different ways. Some may be born with genes that make them more likely to get this type of skin cancer. Genes are made up of DNA. DNA damage ...
What is the current status of trial NCT00615095?
This trial is currently completed. The enrollment target is 323 participants. The study started on 1997-02. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00615095?
The interventions under investigation include: self-administered questionnaire and blood draw (OTHER), health questionnaire, blood draw and skin exam (OTHER).
Who is sponsoring clinical trial NCT00615095?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.